Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Belumosudil mesylate |
| Trade Name | Rezurock |
| Synonyms | KD025 mesylate|SLx-2119 mesylate|belumosudil |
| Drug Descriptions |
Rezurock (belumosudil mesylate) is a ROCK1/2 inhibitor that potentially induces tumor cell killing and decreases tumor growth (Blood (2023) 142 (Supplement 1): 651). |
| DrugClasses | |
| CAS Registry Number | 2109704-99-4 |
| NCIT ID | C175056 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Belumosudil mesylate | Belumosudil mesylate | 0 | 1 |